ArticleNPJ precision oncology2025

Targeting cancer-associated fibroblast-driven LIF/LIFR axis improves the therapeutic efficacy of gemcitabine and nab-paclitaxel in pancreatic cancer.

Rakesh Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.